Literature DB >> 433968

Myasthenia gravis, thymectomy and serum thymic hormone activity.

J J Twomey, V M Lewis, B M Patten, G Goldstein, R A Good.   

Abstract

Serum thymic hormone activity was measured in 36 patients with myasthenia gravis and in 10 control subjects from each age decade. In all 25 patients under 50 years of age results were within, or close to, the normal range. Activity at levels considered normal for juveniles was detected in 10 of the 11 older patients whereas levels normally decline in older subjects. One week after thymectomy, 13 of 17 patients (76 per cent) had no demonstrable serum thymic hormone activity. However, 10 months or longer after thymectomy only five patients (30 per cent) lacked thymic hormone activity in the serum. There was a significant correlation between clinial improvement and sustained lowering of serum thymic hormone activity after thymectomy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433968     DOI: 10.1016/0002-9343(79)91175-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Transcervical thymectomy and thymus remnants.

Authors:  M Rosenberg; A J Roncoroni
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

3.  Cervical thymectomy in the treatment of myasthenia gravis.

Authors:  R J Donnelly; M P Laquaglia; B Fabri; M Hayward; A M Florence
Journal:  Ann R Coll Surg Engl       Date:  1984-09       Impact factor: 1.891

4.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 5.  Thymectomy in myasthenia gravis. A review.

Authors:  H J Oosterhuis
Journal:  Ital J Neurol Sci       Date:  1983-12

6.  Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex.

Authors:  W Savino; G Manganella; J M Verley; A Wolff; S Berrih; P Levasseur; J P Binet; M Dardenne; J F Bach
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  Binding of thymopoietin to the acetylcholine receptor.

Authors:  K Venkatasubramanian; T Audhya; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.